2-(Ethylamino)-1,2-diphenylethanone
2-(Ethylamino)-1,2-diphenylethanone (also known as [alpha-(Ethylamino)benzyl]-(phenyl)-ketone and βk-Ephenidine) is a chemical compound invented by AstraZeneca which is claimed as an inhibitor of the enzyme 11β-Hydroxysteroid dehydrogenase type 1.[1] No other pharmacological data has been disclosed, though its chemical structure closely resembles that of certain designer drug compounds such as ephenidine and N-ethylhexedrone.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
Chemical and physical data | |
Formula | C16H17NO |
Molar mass | 239.318 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.